Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 817-825

  Thomas, Sarah A ^a,c   Abbruscato, Thomas J ^a   Hau, Vincent S ^a   Gillespie, Terrence J ^a   Zsigo, Joseph ^b   Hruby, Victor J ^b   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DELTORPHIN; DELTORPHIN I [2 DEXTRO ALANINE]; DELTORPHIN I [2 DEXTROALANINE] DERIVATIVE; DELTORPHIN II [2 DEXTRO ALANINE]; DELTORPHIN II [2 DEXTROALANINE] DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CATTLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANALGESICS, OPIOID; ANIMALS; BLOOD-BRAIN BARRIER; CATTLE; HALF-LIFE; MALE; MICE; MICE, INBRED ICR; OLIGOPEPTIDES; RECURRENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030911575     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. AHMAD, S. AND WARD, P. E.: Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P. Proc. Soc. Exptl. Biol. Med. 200: 115-121, 1992.
2. AUDUS, K. L. AND BORCHARDT, R. T.: Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 3: 81-87, 1986.
3. BODOR, N., PROKAI, L., WU, W. M., FARAG, H., JONALAGADDA, S., KAWAMURA, M. AND SIMPKINS, J. A.: Strategy for delivering peptides into the central nervous system by sequential metabolism. Science 257: 1698-1700, 1992.
4. BONGERS, J., LAMBROS, T., AHMAD, M. AND HEIMER, E. P.: Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs. Biochim. Biophys. Acta 1122: 147-153, 1992.
5. BROWNLEES, J. AND WILLIAMS, C.: Peptidases and Peptides at the Blood-Brain Barrier, ed. by G. O'Cuinn, pp. 159-199, CRC Press, London, 1995.
6. BROWNSON, A. E., ABBRUSCATO, T. J., GILLESPIE, T. J., HRUBY, V. J. AND DAVIS, T. P.: Effect of peptidases at the blood-brain barrier on the permeability of enkephalin. J. Pharm. Exp. Ther. 270: 675-680, 1994.
7. BRUST, P., BECH, A., KRETZSCHMAR, R. AND BERGMANN, R.: Developmental changes of enzymes involved in peptide degradation in isolated rat brain microvessels. Peptides 15: 1085-1088, 1994.
8. BRYANT, S. D., SALVADORI, S., ATTILA, M. AND LAZARUS, L.: Topographical conformations of the deltorphins predicate δ-opioid receptor affinity. J. Am. Chem. Soc. 115: 8503-8504, 1993.
9. CARL, P. L.: Plasmin-activated prodrugs for cancer chemotherapy. In Development of Target-Orientated Anticancer Drugs, ed. by Y. C. Cheng, B. Goz and M. Minkoff, pp. 143-154, Raven Press, New York. 1993.
10. CHECLER, F.: Neuropeptide-Degrading Peptidases, ed. by S. H. Parvez, M. Naoi, T. Nagatsu and S. Parvez, pp. 375-417, Elsevier Science Publishers, New York. 1993.
11. CHURCHILL, L., BAUSBACK, H. H., GERRITSEN, M. E. AND WARD, P. E.: Metabolism of opioid peptides by cerebral microvascular aminopeptidase M. Biochim. Biophys. Acta 923: 35-41, 1987.
12. DAHMS, P. AND MENTLEIN, R.: Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur. J. Pharmcol. 208: 145-154, 1992.
13. DAUCH, P., MASUO, Y., VINCENT, J-P. AND CHECLER, F.: A survey of the cerebral regionalization and ontogeny of eight exo-and endopeptidases in murines. Peptides 14: 593-599, 1993.
14. DAVIS, T. P.: Methods of measuring neuropeptides and their metabolism. In The Roles of Neuropeptides in Stress Pathogenesis and Systemic Disease, ed. by P. G. Kaufman, J. A. McCubbin and C. B. Nemeroff, Academic Press. Inc., Orlando, FL, 1990.
15. DAVIS, T. P. AND CULLING-BERGLUND, A.: High-performance liquid Chromatographic analysis of in vitro central neuropeptide processing. J. Chromatogr. 327: 279-292, 1985.
16. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. AND KREIL, G.: Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 86: 5188-5192, 1989.
17. FREDERICKSON, R. C. A., SMITHWICK, E. L., SHUMAN, R. AND BEMIS, K. G.: Metkephamid, a systemically active analog of methionine enkephalin with potent delta-receptor activity. Science 211: 603-605, 1981.
18. GILLESPIE, T. J., KONINGS, P. N. M., MERRILL, B. J. AND DAVIS, T. P.: A specific enzyme assay for aminopeptidase M in rat brain. Life Sci. 51: 2097-2106, 1992.
19. GREENE, D. L., HAU, V. S., ABBRUSCATO, T. J., BARTOSZ, H., MISIEKA, A., LIPKOWSKI, A. W., HOM, S., GILLESPIE, T. J., HRUBY, V. J. AND DAVIS, T. P.: Enkephalin analog pro-drugs: An assessment of in vitro conversion, enzymatic cleavage characterization and blood-brain barrier permeability. J. Pharm. Exp. Ther. 277: 1366-1375, 1996.
20. GRIFFIN, D. E. AND GIFFELS, J.: Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J. Clin. Invest. 70: 289-295, 1982.
21. 4]-substituted derivatives: Further evidence of opioid delta receptor multiplicity. J. Pharm. Exp. Ther. 265: 896-902, 1993.
22. JI, H., ZHANG, R., HU, X., LAI, L. AND XU, X.: Synthesis, conformation and opioid activity of deltorphins. Biochem. Biophys. Res. Commun. 207: 99-104, 1995.
23. 2]deltorphin II, a highly selective δ agonist in vivo. Life Sci. 47: PL43-47, 1990.
24. KATO, T., NAGATSU, T., FUKASAWA, K., HARANDO, M., NAGATSU, I. AND SAKAKIBARA, S.: Successive cleavage of N-terminal Arg-Pro and Lys-Pro from substance P but not release of Arg-Pro from bradykinin by X-Pro dipeptidyl aminopeptidase. Biochim. Biophys. Acta 525: 417-422, 1978.
25. KRAMER, T. H., TOTH, G., HAASETH, R. C., MATSUNAGA, T. O., DAVIS, P., HRUBY, V. J. AND BURKS, T. F.: Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro. Life Sci. 48:881-886, 1991.
26. KREIL, G., BARRA, D., SIMMACO, M., ERSPAMER, V., FALCONIERI-ERSPAMER, G., NEGRI, L., SEVERINI, C., CORSI, R. AND MELCHIORRI, P.: Deltorphin, a novel amphibian skin peptide with high affinity for δ opioid receptors. Eur. J. Pharmacol. 162: 123-128, 1989.
27. KUMAGAI, A. K., EISENBERG, J. B. AND PARDRIDGE, W. M.: Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. J. Biol. Chem. 262: 15214-15219, 1987.
28. LAZARUS, L. H., BRYANT, S. D., SALVADORI, S., ATTILA, M. AND SARGENT-JONES, L.: Opioid infidelity: Opioid peptides with dual high affinity for δ-and μ-receptors. Trends Neurosci. 19: 31-35, 1996.
29. LAZARUS, L. H., SALVADORI, S., SANTAGADA, V., TOMATIS, R. AND WILSON, W. E.: Function of negative charge in the "address domain" of deltorphins. J. Med. Chem. 34: 1350-1355, 1991.
30. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
31. MARASTONI, M., TOMATIS, R., BALBONI, G., SALVADRI, S. AND LAZARUS, L. H.: On the degradation of the deltorphin peptides by plasma and brain homogenate. Farmaco 46: 1273-1279, 1991.
32. MCLELLAN, S., DYER, S. H., RODRIGUEZ, G. AND HERSH, L. B.: Studies on the tissue distribution of the puromycin-sensitive enkephalin-degrading aminopeptidases. J. Neurochem. 51: 1552-1559, 1988.
33. MELCHIORRI, P., NEGRI, L., FALCONIERI ERSPAMER, G., SEVERINI, C., CORSI, R., SOAJE, M., ERSPAMER, V. AND BARRA, D.: Structure-activity relationships of the δ-opioid-selective agonists, deltorphins. Eur. J. Pharmacol. 195: 201-207, 1991.
34. MENTLEIN, R.: Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS. Lett. 234: 251-256, 1988.
35. MENTLEIN, R. AND DAHMS, P.: Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 62: 27-36, 1994.
36. MENTLEIN, R., DAHMS, P., GRANDT, D. AND KRÜGER, R.: Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Peptides 49: 133-144, 1993a.
37. MENTLEIN, R., GALLWITZ, B. AND SCHMIDT, W. E.: Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214: 829-835, 1993b.
38. MISICKA, A., LIPKOWSKI, A. W., FANG, L., KNAPP, R. J., DAVIS, P., KRAMMER, T., BURKS, T. F., YAMAMURA, H. I., CARR, D. B. AND HRUBY, V. J.: Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity. Biochem. Biophys. Res. Commun. 180: 1290-1297, 1991.
39. MISICKA, A., LIPKOWSKI, A. W., HORVATH, R., DAVIS, P., YAMAMUKA, H. I., PORRECA, F. AND HRUBY, V. J.: Design of cyclic deltorphins and dermenkephalins with a disulphide bridge leads to analogues with high selectivity for delta-opioid receptors. J. Med. Chem. 37: 141-145, 1994.
40. Moss, J.: Peptide pro-drugs designed to limit metabolism. In Peptide-Based Drug Design: Controlling Transport and Metabolism, 1st ed, pp. 423-448, ACS Professional Reference Book,. Washington, D.C., 1995.
41. NIKIFOROVICH, G. V. AND HRUBY, V. J.: Examination of the conformational meaning of "δ-address" in the dermenkephalin sequence. Biochem. Biophys. Res. Commun. 173: 521-527, 1990.
42. PALMIERI, F. E., PETRELLI, J. J. AND WARD, P. E.: Vascular, plasma membrane amiopeptidase M. Biochem. Pharmac. 34: 2309-2317, 1985.
43. PARDRIDGE, W. M.: Peptide Drug Delivery to the Brain. Raven Press, New York, 1991.
44. PARDRIDGE, W. M., TRIGUERO, D., YANG, J. AND CANCILLA, P. A.: Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharm. Exp. Ther. 253: 884-891, 1990.
45. PORTOGHESE, P. S.: Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 10: 230-235, 1989.
46. SAGAN, S., AMICHE, M., DELFOUR, A., CAMUS, A., MOR, A. AND NICOLAS, P.: Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency. Biochem. Biophys. Res. Commun. 163: 726-732, 1989a.
47. SAGAN, S., AMICHE, M., DELFOUR, A., MOR, A., CAMUS, A. AND NICOLAS, P.: Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin. J. Biol. Chem. 264: 17100-17106, 1989b.
48. SAGAN, S., CHARPENTIER, S., DELFOUR, A., AMICHE, M. AND NICOLAS, P.: The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independent of receptor binding. Biochem. Biophys. Res. Commun. 187: 1203-1210, 1992.
49. 4]deltorphin C analogues: novel probes for the δ-opioid receptor. Eur. J. Pharm. 230: 357-361, 1993.
50. SALVADORI, S., MARASTONI, M., BALBONI, G., BOREA, P. A., MORARI, M. AND TOMATIS, R.: Synthesis and structure-activity relationships of deltorphin analogues. J. Med. Chem. 34: 1656-1661, 1991.
51. 2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor. Biochem. Biophys. Res. Commun. 180: 822-827, 1991.
52. SASAKI, Y., CHIBA, T., AMBO, A. AND SUZUKI, K.: Degradation of deltorphin and their analogs by rat brain synaptosomal peptidases. Chem. Pharm. Bull. 42: 592-594, 1994.
53. SCHNABEL, R., BERNSTEIN, H. G., LUPPA, H., LOJDA, Z. AND BARTH, A.: Aminopeptidases in the circvumventricular organs of the mouse brain: A histochemical study. Neuroscience 47: 431-438, 1992.
54. SCHWYZER, R.: Molecular mechanism of opioid receptor selection. Biochemistry 25: 6335-6342, 1986.
55. SHIBANOKI, S., WEINBERGER, S. B., ISHIKAWA, K. AND MARTINEZ, JR.: Further-characterization of the in vitro hydrolysis of [Leu]-and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations. Regul. Peptides 32: 267-278, 1991.
56. SHIMURA, T., TABATA, S., OHNISHI, T., TERASAKI, T. AND TSUJI, A.: Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier. J. Pharmacol. Exp. Ther. 258: 459-465, 1991.
57. SHOOK, J. E., PELTON, J. T., HRUBY, V. J. AND BURKS, T. F.: Peptide opioid antagonist separates peripheral and central opioid antitransit effects. J. Pharm. Exp. Ther. 243: 492-500, 1987.
58. TALLARIDA, R. J. AND MURRAY, R. B.: First-order drug decay. In Manual of Pharmacological Calculations with Computer Programs, 2nd ed. pp. 69-71, Spinger-Verlag, New York, 1987.
59. TERASAKI, T., ICHIHIRAI, K., SATO, H., KANG, Y. S. AND TSUJI, A.: Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier. J. Pharm. Exp. Ther. 251: 351-357, 1989.
60. VAN DEURS, G., VON BÜLOW, F. AND MØLLER, M.: Vesicular transport of cationized ferritin by the epithelium of the rat choroid plexus. J. Cell Biol. 89: 359-368, 1989.
61. VANHOOF, G., GOOSSENS, F., DE MEESTER, I., HENDRIKS, D. AND SCHARPÉ, T. P.: Proline motifs in peptides and their biological processing. FASEB J. 9: 736-744, 1995.
62. VORBRODT, A. W.: Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J. Neurocytol. 18: 359-368, 1989.
63. WATERS, S. M., KONKOY, C. S. AND DAVIS, T. P.: Haloperidol and apomorphine differentially affect neuropeptidase activity. J. Pharmacol. Exp. Ther. 277: 113-120, 1996.
64. 5]enkephalin opioid analogs. J. Pharmacol. Exp. Ther. 266: 1649-1655, 1993.
65. 5]enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration. J. Pharmacol. Exp. Ther. 263: 1308-1316, 1992.
66. 2,5]enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. J. Neurochem. 66: 1289-1299, 1996.
67. ZLOKOVIC, B. V., MACKIC, J. B., DJURICIC, B. AND DANVSON, H.: Kinetic analysis of leucine enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 53: 1333-1340, 1989.